XML 47 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Schedule Of Valuation Of The Intangible Assets Acquired And Related Amortization Periods) (Details) (Paladin Labs Inc. [Member], USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) $ 650,248
Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 523,700
In Process Research & Development [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 126,500
Other Intangible Assets [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 650,200
Canada Base Prescription Segment [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 345,000
Amortization Period (in years) 12 years
Canada OTC Segment [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 40,000
Amortization Period (in years) 11 years
Canada Other Segment [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 69,200
Amortization Period (in years) 11 years
Litha Segment [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 60,000
Amortization Period (in years) 12 years
Latin America Segment [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 5,000
Amortization Period (in years) 15 years
Licenses Not Renewed [Member] | Developed Technology [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 4,500
Amortization Period (in years) 3 years
Serelaxin [Member] | In Process Research & Development [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) 115,000
Other Intangible Assets [Member] | In Process Research & Development [Member]
 
Acquired Finite-Lived Intangible Assets [Line Items]  
Valuation (in millions) $ 11,500